Please assess the completion status of the following clinical trial:

Trial Title: Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Consenting patients were eligible for enrollment if they:~  1. were 18-65 years of age,~ 2. had endoscopically diagnosed active duodenal ulcers within the previous 72 hours,~ 3. the number of ulcers was at least one, but no more than two with the larger diameter 0.3-2.0cm.~Exclusion Criteria:~* Patients were ineligible if they:~  1. had cancerous or complex ulcers, Zollinger-Ellison syndrome, esophageal erosion or ulcer, varices of esophagus or fundus of stomach, or pyloric stenosis,~ 2. had a known history of gastric acid suppression operation, esophageal operation or peptic operation other than simple closure of perforation,~ 3. had severe complications (e.g., pyloric obstruction, active bleeding under endoscope), severe other diseases of digestive tract such as Crohn's disease and ulcerative colitis, and severe other systemic diseases,~ 4. were female patients who were breast feeding, pregnant, or intended to become pregnant during the study,~ 5. had taken proton pump inhibitors within the 5 days or for more than three consecutive days within the two weeks immediately preceding start of study drug,~ 6. participated in a clinical trial with an investigational drug or device within the past three months,~ 7. had hypersensitivity or idiosyncratic reaction to omeprazole or any other benzimidazole,~ 8. had alcoholic intemperance, drug addiction or any other improper habits.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 5 mg ilaprazole (Type: EXPERIMENTAL): None
- 10 mg ilaprazole (Type: EXPERIMENTAL): None
- 20 mg ilaprazole (Type: EXPERIMENTAL): None
- 20 mg omeprazole (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).